Frank-Peter Tillmann
7PUBLICATIONS
1CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Feb 02, 2023
Patiromer utilization in patients with advanced chronic kidney disease under nephrology care in Germany.Roberto Pecoits-Filho, Keith McCullough, Daniel Muenz
|Jun 10, 2022
Effect of Third and Fourth mRNA-Based Booster Vaccinations on SARS-CoV-2 Neutralizing Antibody Titer Formation, Risk Factors for Non-Response, and Outcome after SARS-CoV-2 Omicron Breakthrough Infections in Patients on Chronic Hemodialysis: A Prospective Multicenter Cohort Study.Frank-Peter Tillmann, Lars Figiel, Johannes Ricken
|Dec 03, 2021
Long-term trajectories of SARS-CoV-2 neutralizing antibodies and predictive value of first dose vaccination-induced IgG-antibodies in hemodialysis patients.F P Tillmann, H Still, Philipp von Landenberg
|Nov 13, 2021
Evolution of SARS-CoV-2-Neutralizing Antibodies after Two Standard Dose Vaccinations, Risk Factors for Non-Response and Effect of a Third Dose Booster Vaccination in Non-Responders on Hemodialysis: A Prospective Multi-Centre Cohort Study.Frank-Peter Tillmann, Lars Figiel, Johannes Ricken
|Mar 30, 2019
Effect of recipient-donor sex and weight mismatch on graft survival after deceased donor renal transplantation.Frank-Peter Tillmann, Ivo Quack, Magdalena Woznowski
|Jun 28, 2018
HbA1c levels at 90 days after renal transplantation in non-diabetic recipients predict de novo pre-diabetes and diabetes at 1 and 3 years after transplantation.Frank-Peter Tillmann, Lars Christian Rump, Ivo Quack
Pageof 2
